MC Jung

711 total citations · 1 hit paper
7 papers, 602 citations indexed

About

MC Jung is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, MC Jung has authored 7 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 5 papers in Epidemiology and 1 paper in Infectious Diseases. Recurrent topics in MC Jung's work include Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (4 papers) and Liver Disease Diagnosis and Treatment (2 papers). MC Jung is often cited by papers focused on Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (4 papers) and Liver Disease Diagnosis and Treatment (2 papers). MC Jung collaborates with scholars based in Germany, United States and Netherlands. MC Jung's co-authors include Helmut M. Diepolder, Robert M. Hoffmann, D. Eichenlaub, Teresa Santantonio, G. R. Pape, Roman Zachoval, E A Wierenga, H Hartmann, Katyna Borroto–Esoda and David Oldach and has published in prestigious journals such as The Lancet and Zeitschrift für Gastroenterologie.

In The Last Decade

MC Jung

7 papers receiving 584 citations

Hit Papers

Possible mechanism involving T-lymphocyte response to non... 1995 2026 2005 2015 1995 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MC Jung Germany 3 548 355 173 96 92 7 602
Carl Albrecht Schirren Germany 10 549 1.0× 377 1.1× 215 1.2× 90 0.9× 71 0.8× 11 645
M.C. Jung Germany 11 435 0.8× 333 0.9× 165 1.0× 69 0.7× 58 0.6× 18 539
Ahmed Fatmi France 7 475 0.9× 345 1.0× 259 1.5× 51 0.5× 91 1.0× 8 600
Suzanne E. Bassett United States 9 511 0.9× 418 1.2× 77 0.4× 66 0.7× 83 0.9× 9 676
Nadine Kersting Germany 9 364 0.7× 249 0.7× 358 2.1× 40 0.4× 75 0.8× 12 589
Karen Fitzmaurice Ireland 8 281 0.5× 190 0.5× 122 0.7× 59 0.6× 67 0.7× 13 371
Kathrin Hueging Germany 10 398 0.7× 318 0.9× 38 0.2× 71 0.7× 70 0.8× 10 511
Allan G. N. Angus United Kingdom 11 438 0.8× 334 0.9× 54 0.3× 43 0.4× 66 0.7× 12 560
N Nazarova Germany 3 238 0.4× 191 0.5× 218 1.3× 36 0.4× 72 0.8× 3 418
Olivier Vidalin France 8 306 0.6× 249 0.7× 73 0.4× 31 0.3× 48 0.5× 8 413

Countries citing papers authored by MC Jung

Since Specialization
Citations

This map shows the geographic impact of MC Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MC Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MC Jung more than expected).

Fields of papers citing papers by MC Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MC Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MC Jung. The network helps show where MC Jung may publish in the future.

Co-authorship network of co-authors of MC Jung

This figure shows the co-authorship network connecting the top 25 collaborators of MC Jung. A scholar is included among the top collaborators of MC Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MC Jung. MC Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Buggisch, Peter, S Mauss, Bernd Weber, et al.. (2020). Barrieren der Hepatitis-C-Virus (HCV) Elimination in Deutschland: warum erhalten diagnostizierte Patienten keine Therapie?. Zeitschrift für Gastroenterologie. 2 indexed citations
2.
Vermehren, Johannes, Albrecht Stoehr, Julian Schulze zur Wiesch, et al.. (2018). Re-Therapie von DAA-Versagern mit Sofosbuvir/Velpatasvir/Voxilaprevir – Ergebnisse aus dem Deutschen Hepatitis C-Register (DHC-R). Zeitschrift für Gastroenterologie. 56(8). e290–e290. 1 indexed citations
3.
Deterding, Katja, Peter Buggisch, Johannes Wiegand, et al.. (2012). Early versus delayed treatment of acute hepatitis C: Final results of the randomized controlled German HEP-NET acute HCV-III study. Zeitschrift für Gastroenterologie. 50(1). 4 indexed citations
4.
Deterding, Katja, Johannes Wiegand, Peter Buggisch, et al.. (2009). Präsidentenposter: Early versus delayed treatment of acute hepatitis C: The German HEP-NET acute HCV-III study – a randomized controlled trial. Zeitschrift für Gastroenterologie. 47(9). 2 indexed citations
5.
Berg, Thomas, Bjarne Kuno Møller, G Gerken, et al.. (2008). Tenofovir disoproxil fumarate (TDF) versus Emtricitabine plus TDF for treatment of chronic Hepatitis B (CHB) in subjects with persistent viral replication receiving Adefovir dipivoxil (ADV). Zeitschrift für Gastroenterologie. 46(9). 6 indexed citations
6.
Sung, Gun Yong, et al.. (2007). Recent Trend in the Ubiquitous Life-Care Technology. 1 indexed citations
7.
Diepolder, Helmut M., Roman Zachoval, Robert M. Hoffmann, et al.. (1995). Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. The Lancet. 346(8981). 1006–1007. 586 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026